-
1Academic Journal
Authors: A. S. Dzasokhov, A. A. Kostin, V. L. Astashov, A. V. Turiev, A. D. Uskov, А. С. Дзасохов, А. А. Костин, В. Л. Асташов, А. В. Туриев, А. Д. Усков
Source: Research and Practical Medicine Journal; Том 10, № 1 (2023); 100-110 ; Research'n Practical Medicine Journal; Том 10, № 1 (2023); 100-110 ; 2410-1893 ; 10.17709/2410-1893-2023-10-1
Subject Terms: индекс перитонеального карциноматоза, ascites, peritoneal carcinomatosis, drug pathomorphosis, intraperitoneal chemotherapy, pressurized intraperitoneal aerosol chemotherapy, Peritoneal Cancer Index (PCI), асцит, перитонеальный канцероматоз, лекарственный патоморфоз, внутрибрюшная химиотерапия, внутрибрюшная аэрозольная химиотерапия под давлением
File Description: application/pdf
Relation: https://www.rpmj.ru/rpmj/article/view/882/542; Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. М.: МНИОИ им. П. А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022, 239 с. Доступно по: https://glavonco.ru/cancer_register/ЗИС%202021%20эл.%20версия.pdf. Дата обращения: 10.02.2023.; Степанов И. В., Падеров Ю.М., Афанасьев С. Г. Перитонеальный канцероматоз. Сибирский онкологический журнал. 2014;5:45–53.; Радостев С. И., Шелехов А. В., Дворниченко В. В., Мориков Д. Д., Расулов Р. И., Медведников А. А., Николаева Н. А. Результаты лечения больных раком яичников с явлениями перитонеального канцероматоза. Онкология. Журнал им. П.А. Герцена. 2020;9(6):5–11. https://doi.org/10.17116/onkolog202090615; Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. https://doi.org/10.3322/caac.21492. Erratum in: CA Cancer J Clin. 2020 Jul;70(4):313; Lowe KA, Chia VM, Taylor A, O’Malley C, Kelsh M, Mohamed M, Mowat FS, Goff B. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol. 2013 Jul;130(1):107–114. https://doi.org/10.1016/j.ygyno.2013.03.026; Chang SJ,Hodeib M,Chang J,Bristow RE.Survival impact of complete cytoreduction to no gross residual disease for advanced‑stage ovarian cancer: a meta‑analysis. Gynecol Oncol. 2013 Sep;130(3):493–498. https://doi.org/10.1016/j.ygyno.2013.05.040; Cortez AJ,Tudrej P,Kujawa KA,Lisowska KM.Advances in ovarian cancer therapy.Cancer Chemother Pharmacol.2018 Jan;81(1):17–38. https://doi.org/10.1007/s00280‑017‑3501‑8; Клинические рекомендации «Рак яичников, рак маточной трубы, первичный рак брюшины». М., Ассоциация онкологов России; 2020. Доступно по: https://oncology‑association.ru/wp‑content/uploads/2021/03/rak‑yaichnikov_matochnoj‑truby_. pdf. Дата обращения: 10.02.2023.; Dochez V, Caillon H, Vaucel E, Dimet J, Winer N, Ducarme G. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res. 2019 Mar 27;12(1):28. https://doi.org/10.1186/s13048‑019‑0503‑7; Cui R, Wang Y, Li Y, Li Y. Clinical value of ROMA index in diagnosis of ovarian cancer: meta‑analysis. Cancer Manag Res. 2019 Mar 28;11:2545–2551. https://doi.org/10.2147/cmar.s199400; Santotoribio JD, Garcia‑de la Torre A, Cañavate‑Solano C, Arce‑Matute F, Sanchez‑del Pino MJ, Perez‑Ramos S. Cancer antigens 19.9 and 125 as tumor markers in patients with mucinous ovarian tumors. Eur J Gynaecol Oncol. 2016;37(1):26–29.; Zhang L, Chen Y, Wang K. Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis. Curr Probl Cancer. 2019 Apr;43(2):135–144. https://doi.org/10.1016/j.currproblcancer.2018.06.001; Lertkhachonsuk AA, Buranawongtrakoon S, Lekskul N, Rermluk N, Wee‑Stekly WW, Charakorn C. Serum CA19‑9, CA‑125 and CEA as tumor markers for mucinous ovarian tumors. J Obstet Gynaecol Res. 2020 Nov;46(11):2287–2291. https://doi.org/10.1111/jog.14427; Grandi G, Fiocchi F, Cortesi L, Toss A, Boselli F, Sammarini M, et al. The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6‑month follow‑up program: results from a 6‑years surveillance. Menopause. 2021 Nov 1;29(1):63–72. https://doi.org/10.1097/gme.0000000000001883; Roze JF, Hoogendam JP, van de Wetering FT, Spijker R, Verleye L, Vlayen J, Veldhuis WB, Scholten RJ, Zweemer RP. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian/ fallopian tube/primary peritoneal cancer. Cochrane Database Syst Rev. 2018 Oct 8;10(10):CD012567. https://doi.org/10.1002/14651858.cd012567.pub2; Wubulihasimu M, Maimaitusun M, Xu XL, Liu XD, Luo BM. The added value of contrast‑enhanced ultrasound to conventional ultrasound in differentiating benign and malignant solid breast lesions: a systematic review and meta‑analysis. Clin Radiol. 2018 Nov;73(11):936–943. https://doi.org/10.1016/j.crad.2018.06.004; Kuroki L, Guntupalli SR. Treatment of epithelial ovarian cancer. BMJ. 2020 Nov 9;371:m3773. https://doi.org/10.1136/bmj.m3773; Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL, et al. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol. 2016 Oct;143(1):3–15. https://doi.org/10.1016/j.ygyno.2016.05.022; Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol. 1998 Apr‑May;14(3):254–261.; Helm CW, Richard SD, Pan J, Bartlett D, Goodman MD, Hoefer R, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER‑O registry. Int J Gynecol Cancer. 2010 Jan;20(1):61–69. https://doi.org/10.1111/igc.0b013e3181c50cde; Narod S. Can advanced‑stage ovarian cancer be cured? Nat Rev Clin Oncol. 2016 Apr;13(4):255–261. https://doi.org/10.1038/nrclinonc.2015.224; Sticca RP, Dach BW. Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. Surg Oncol Clin N Am. 2003 Jul;12(3):689–701.; Lim MC, Chang SJ, Park B, Yoo HJ, Yoo CW, Nam BH, Park SY; HIPEC for Ovarian Cancer Collaborators. Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial. JAMA Surg. 2022 May 1;157(5):374–383. https://doi.org/10.1001/jamasurg.2022.0143; El‑Kareh AW, Secomb TW. A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance. Neoplasia. 2004 Mar‑Apr;6(2):117–127. https://doi.org/10.1593/neo.03205; González‑Moreno S, González‑Bayón LA, Ortega‑Pérez G. Hyperthermic intraperitoneal chemotherapy: Rationale and technique. World J Gastrointest Oncol. 2010 Feb 15;2(2):68–75. https://doi.org/10.4251/wjgo.v2.i2.68; de Bree E, Tsiftsis DD. Experimental and pharmacokinetic studies in intraperitoneal chemotherapy: from laboratory bench to bedside. Recent Results Cancer Res. 2007;169:53–73. https://doi.org/10.1007/978‑3‑540‑30760‑0_5; Reymond MA, Schneider C, Hohenberger W, Köckerling F. The pneumoperitoneum and its role in tumor seeding. Dig Surg. 1998;15(2):105–109. https://doi.org/10.1159/000018602; Reymond MA, Hu B, Garcia A, Reck T, Köckerling F, Hess J, Morel P. Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator. Surg Endosc. 2000 Jan;14(1):51–55. https://doi.org/10.1007/s004649900010; Solaß W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc. 2012 Jul;26(7):1849–1855. https://doi.org/10.1007/s00464‑012‑2148‑0; Solass W, Herbette A, Schwarz T, Hetzel A, Sun JS, Dutreix M, Reymond MA. Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc. 2012 Mar;26(3):847–852. https://doi.org/10.1007/s00464‑011‑1964‑y; Blanco A, Giger‑Pabst U, Solass W, Zieren J, Reymond MA. Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC). Ann Surg Oncol. 2013 Jul;20(7):2311–2316. https://doi.org/10.1245/s10434‑012‑2840‑2; Solass W, Giger‑Pabst U, Zieren J, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy (PIPAC): occupational health and safety aspects. Ann Surg Oncol. 2013 Oct;20(11):3504–3511. https://doi.org/10.1245/s10434‑013‑3039‑x; Solass W, Kerb R, Mürdter T, Giger‑Pabst U, Strumberg D, Tempfer C, Zieren J, Schwab M, Reymond MA. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol. 2014 Feb;21(2):553–559. https://doi.org/10.1245/s10434‑013‑3213‑1; Baert T, Ferrero A, Sehouli J, O’Donnell DM, González‑Martín A, Joly F, van der Velden J, Blecharz P, Tan DSP, Querleu D, Colombo N, du Bois A, Ledermann JA. The systemic treatment of recurrent ovarian cancer revisited. Ann Oncol. 2021 Jun;32(6):710–725. https://doi.org/10.1016/j.annonc.2021.02.015; Tempfer CB, Winnekendonk G, Solass W, Horvat R, Giger‑Pabst U, Zieren J, Rezniczek GA, Reymond MA. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study. Gynecol Oncol. 2015 May;137(2):223–228. https://doi.org/10.1016/j.ygyno.2015.02.009; Каприн А. Д., Хомяков В. М., Рябов А. Б., Болотина Л. В., Иванов А. В., Уткина А. Б., и др. Внутрибрюшная аэрозольная химиотерапия под давлением (ВАХД) – инновационный метод лечения больных с перитонеальным канцероматозом. Research’n Practical Medicine Journal. 2016;3(2):22–30. https://doi.org/10.17709/2409‑2231‑2016‑3‑2‑3; Nowacki M, Alyami M, Villeneuve L, Mercier F, Hubner M, Willaert W, et al. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. Eur J Surg Oncol. 2018 Jul;44(7):991–996. https://doi.org/10.1016/j.ejso.2018.02.014; Дзасохов А. С., Костин А. А., Асташов В. Л., Хомяков В. М., Усков А. Д., Андреева М. А., Уткина А. Б. Описание первого клинического случая комбинации хирургической циторедукции и внутрибрюшной аэрозольной химиотерапии под давлением при лечении рака яичников. Онкология. Журнал им. П.А. Герцена. 2021;10(2):44–49. https://doi.org/10.17116/onkolog20211002144; https://www.rpmj.ru/rpmj/article/view/882
-
2Academic Journal
Authors: D. V. Sidorov, N. A. Grishin, M. V. Lozhkin, A. A. Troitsky, R. I. Moshurov, S. A. Bykasov, A. N. Urlova, E. V. Filonenko, Д. В. Сидоров, Н. А. Гришин, М. В. Ложкин, А. А. Троицкий, Р. И. Мошуров, С. А. Быкасов, А. Н. Урлова, Е. В. Филоненко
Source: Biomedical Photonics; Том 9, № 4 (2020); 23-30 ; 2413-9432 ; 10.24931/2413-9432-2020-9-4
Subject Terms: циторедуктивная операция, photodynamic therapy, hyperthermic chemotherapy, peritoneal carcinomatosis index, cytoreductive surgery, фотодинамическая терапия, гипертермическая химиотерапия, индекс перитонеального карциноматоза
File Description: application/pdf
Relation: https://www.pdt-journal.com/jour/article/view/455/328; https://www.pdt-journal.com/jour/article/view/455/341; Lord A. C., Shihab O., Chandrakumaran K., Mohamed F., Cecil T. D., Moran B. J. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours//Eur J Surg Oncol. – 2015. – Vol. 41 (3). – P. 396–9. doi:10.1016/j.ejso.2014.08.476.; Sparks D. S., Morris B., Xu W., Fulton J., Atkinson V., Meade B., Lutton N. Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix//Int Surg. – 2015. – Vol. 100 (1). – P. 21–8. doi:10.9738/INTSURGD‑14–00089.1; Arnason T., Kamionek M., Yang M., Yantiss R. K., Misdraji J. Significance of proximal margin involvement in low-grade appendiceal mucinous neoplasms//Arch Pathol Lab Med. – 2015. – Vol. 139 (4). – P. 518–521.; Overman M. J., Fournier K., Hu C. Y., Eng C., Taggart M., Royal R., Mansfield P., Chang G. J. Improving the AJCCTNM staging for adenocarcinomas the appendix: the prognostic impact of gistological grade//Annals of surgery. – 2013. – Vol. 257 (6). – P. 1072–1078.; Grishin, N. A., Suleimanov, E. A., Lozhkin, M. N., Chissov, V. I., Urlova, A. N., Shul’Gin, M. A., Kaprin, A. D., Filonenko, E. V. Cytoreductive surgical treatment with intraoperative photodynamic therapy in patients with mucinous peritoneal carcinomatosis// Biomedical Photonics. – 2017. – Vol. 6 (3). – P. 49–52.; Sokolov V. V., Chissov V. I., Filonenko E. V., Zharkova, N. N., Kozlov, D. N., Smirnov V. V., Clinical fluorescence diagnostics in the course of photodynamic therapy of cancer with the photosensitizer PHOTOGEM//Proceedings of SPIE – The International Society for Optical Engineering. – 1995. – Vol. 2325. – P. 375–380.; Filonenko E. V. The history of development of fluorescence diagnosis and photodynamic therapy and their capabilities in oncology//Russian Journal of General Chemistry. – 2015. – Vol. 85 (1). – P. 211–216.; Sokolov V. V., Chissov V. I., Filonenko E. V., Yakubovskaya R. I., Sukhin D. G., Galpern M. G., Vorozhtsov G. N., Gulin A. V., Zhitkova, M. B., Zharkova, N. N., Kozlov D. N., Smirnov V. V. First clinical results with a new drug for PD//Proceedings of SPIE – The International Society for Optical Engineering. – 1995. – Vol. 2325. – P. 364–366.; Robella M., Vaira M., Cinquegrana A., Borsano A., De Simone M. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: risk factors for morbidity and postoperative outcome//Minerva Chir. – 2019. – Vol. 74 (3). – P. 195–202. doi:10.23736/S0026–4733.18.07649–6; Oemrawsingh A., de Boer N. L., Brandt-Kerkhof A. R. M., Verhoef C., Burger J. W. A., Madsen E. V. E. Short-term complications in elderly patients undergoing CRS and HIPEC: A single center’s initial experience//Eur J Surg Oncol. – 2019. – Vol. 45 (3). – P. 383–388. doi:10.1016/j.ejso.2018.10.545; Rizvi S. A., Syed W., Shergill R. Approach to pseudomyxoma peritonei//World J Gastrointest Surg. – 2018. – Vol. 10 (5). – P. 49–56. doi:10.4240/wjgs.v10.i5.49; Сулейманов Э. А. Интраоперационная флуоресцентная диагностика и фотодинамическая терапия больных с первичными и метастатическими опухолями брюшины. Автореферат диссертации на соискание ученой степени доктора мед.наук. – Москва, 2017. – 48 с.
-
3Academic Journal
Authors: N. A. Rubtsova, A. V. Levshakova, A. O. Peshkov, V. M. Khomyakov, A. B. Utkina, D. V. Sidorov, N. A. Grishin, Н. А. Рубцова, А. В. Левшакова, А. О. Пешков, В. М. Хомяков, А. Б. Уткина, Д. В. Сидоров, Н. А. Гришин
Source: Diagnostic radiology and radiotherapy; № 2 (2019); 32-41 ; Лучевая диагностика и терапия; № 2 (2019); 32-41 ; 2079-5343 ; 10.22328/2079-5343-2019-2
Subject Terms: индекс перитонеального карциноматоза, CT, MRI, PCI, компьютерная томография, магнитно-резонансная томография
File Description: application/pdf
Relation: https://radiag.bmoc-spb.ru/jour/article/view/411/342; Соломенный С.В. Перитонеальный канцероматоз и особенности лимфатической системы в его развитии: дис. … канд. мед. наук / ФГБУ «НМИЦ радиологии» МЗ РФ. М., 2018. 132 с.; Meyers M.A. Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid // Am. J. Roentgenol. Radium. Ther. Nucl. Med. 1973. Vol. 119. Р. 198–206.; Coakley F.V., Hricak H. Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist // Clin. Radiol. 1999. Vol. 54. Р. 563–574. DOI:10.1016/S0009-9260(99)90018-1.; Степанов И.В., Падеров Ю.М., Афанасьев С.Г. Перитонеальный канцероматоз // Сибирский онкологический журнал. 2014. № 5. С. 45–53.; Coakley F.V., Choi P.H., Gougoutas C.A. et al. Peritoneal metastases: detection with spiral CT in patients with ovarian cancer // Radiology. 2002. Vol. 223. Р. 495–499.; Соломенный С.В., Минигазимов Р.С. Перитонеальный канцероматоз. Обзор мирового опыта // Креативная хирургия и онкология. 2013. № 4. С. 115–119.; Tentes A.A., Pallas N., Karamveri C., Kyziridis D., Hristakis C. Cytoreduction and HIPEC for peritoneal carcinomatosis of pancreatic cancer // J. Buon. 2018. Mar-Apr; Vol. 23, No. 2. Р. 482–487.; Flanagan M., Solon J., Chang K.H., Deady S., Moran B., Cahill R., Shields C., Mulsow J. Peritoneal metastases from extra-abdominal cancer — A population-based study // European Journal of Surgical Oncology. 2018. Vol. 44 (11). Р. 1811–1817.; Sadeghi B., Arvieux C., Glehen O., Beaujard A.C., Rivoire M., Baulieux J., Fontaumard E., Brachet A., Caillot J.L., Faure J.L., Porcheron J., Peix J.L., François Y., Vignal J., Gilly F.N. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study // Cancer. 2000. Jan. 15; Vol. 88 (2). Р. 358–363.; Давыдов М.И., Тер-ованесов М.Д., Буйденок Ю.В., Полоцкий Б.Е., Горбунова В.А., Абдуллаев А.Г. Гипертермическая интраоперационная интраперитонеальная химиотерапия при раке желудка: существует ли реальная возможность изменить прогноз? // Вестник РОНЦ им. Н. Н. Блохина РАМН. 2010. Т. 21, № 1. С. 11–20.; Sugarbaker P.H. Surgical responsibilities in the management of peritoneal carcinomatosis // J. Surg. Oncol. 2010. Vol. 101. Р. 713–724.; Nougaret S., Addley H.C., Colombo P.E., Fujii S., Al Sharif S.S., Tirumani S.H., Jardon K., Sala E., Reinhold C. Ovarian carcinomatosis: how the radiologist can help plan the surgical approach // Radiographics. 2012. Vol. 32, No. 6. Р. 1775–800; discussion 1800–1803. DOI:10.1148/rg.326125511.; Saif M.W., Siddiqui I.A., Sohail M.A. Management of ascites due to gastrointestinal malignancy // Ann. Saudi Med. 2009. Sep-Oct., Vol. 29 (5). Р. 369–377.; Diop A.D., Fontarensky M., Montoriol P.F., Da Ines D. CT imaging of peritoneal carcinomatosis and its mimics // Diag. and Interv Imaging. 2014. Vol. 95. Р. 861–872.; Duhr C.D., Kenn W., Kickuth R. et al. Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis // World J. Surg. Oncol. 2011. Vol. 9. Р. 171. DOI:10.1186/1477-7819-9-171.; Pasqual E.M., Bertozzi S., Bacchetti S., Londero A.P., Basso S.M., Santeufemia D.A., Lo Re G., Lumachi F. Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery // Anticancer Res. 2014. Vol. 34 (5). Р. 2363–2668.; Klumpp B., Aschoff P., Schwenzer N. et al. Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results // Cancer Imaging. 2014. Vol. 13 (4). Р. 540–547. DOI:10.1102/1470-7330.2013.0044.; Смирнова Г.Ф., Кириченко А.Д., Фетисова Т.И., Лопатин О.Л., Вержбицкая Н.Е., Eгоров А.А. Редкий случай диссеминированного перитонеального лейомиоматоза // Сибирский онкологический журнал. 2010. № 1. С. 85–87.; Woodward P.J., Hosseinzadeh K., Saenger J.S. From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation // Radiographics. 2004. Vol. 24. Р. 225–246. DOI:10.1148/rg.241035178.; Matsuoka Y., Itai Y., Ohtomo K., Nishikawa J., Sasaki Y. Calcification of peritoneal carcinomatosis from gastric carcinoma: a CT demonstration // Eur. J. Radiol. 1991. Vol. 13. Р. 207–208. DOI:10.1016/0720-048X(91)90031-P.; Matsuoka Y., Ohtomo K., Itai Y., Nishikawa J., Yoshikawa K., Sasaki Y. Pseudomyxomaperitonei with progressive calcifications: CT findings // Gastrointest. Radiol. 1992. Vol. 17. Р. 16–18. DOI:10.1007/BF01888499.; Mitchell D.G., Hill M.C., Hill S., Zaloudek C. Serous carcinoma ofthe ovary: CT identification of metastatic calcified implants // Radiology. 1986. Vol. 158. Р. 649–652.; Amin Z., Reznek R.H. Peritoneal metastases // Husband J.E., Reznek R.H., eds. Imaging in oncology. 3rd ed. Informa Healthcare, 2009. Р. 1094–1114.; Pannu H.K., Bristow R.E., Montz F.J., Fishman E.K. Multidetector CT of peritoneal carcinomatosis from ovarian cancer // Radiographics. 2003. Vol. 23. Р. 687–701. DOI:10.1148/rg.233025105.; Pannu H.K., Horton K.M., Fishman E.K. Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers // J. Сomput. Assist. Tomogr. 2003. Vol. 27. Р. 333–340. DOI:10.1097/00004728-200305000-00006.; Mazzei M.A., Khader L., Cirigliano A. et al. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) // Abdom. Imaging. 2013. Vol. 38. Р. 1422–1430.; Franiel T., Diederichs G., Engelken F., Elgeti T., Rost J., Rogalla P. Multi-detector CT in peritoneal carcinomatosis: diagnostic role of thin slices and multiplanar reconstructions // Abdom. Imaging. 2009. Vol. 34. Р. 49–54. DOI:10.1007/s00261-008-9372-z.; Marin D., Catalano C., Baski M. et al. 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings // Abdom. Imaging. 2010. Vol. 35. Р. 694–670. DOI:10.1007/s00261-008-9464-9.; Low R.N. MR imaging of the peritoneal spread of malignancy // Abdom. Imaging. 2007. Vol. 32. Р. 267–283. DOI:10.1007/s00261-007-9210-8.; De Bree B.E., Koops W., Kroger R., Van Ruth S., Witkamp A.J., Zoetmulder F.A. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement // J. Surg. Oncol. 2004. Vol. 86. Р. 64–73. DOI:10.1002/jso.20049.; Иозефи Д.Я., Винидченко М.А., Демченко Н.С. Применение магнитно-резонансной томографии (МРТ) в диагностике и оценке терапевтического эффекта при метастатическом поражении брюшины: обзор литературы и собственный опыт // Главный врач Юга России. 2018. Vol. 1, No. 59. Р. 15–22.; Zhang H., Dai W., Fu C. et al. Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy // Cancer Biol. Med. 2018. Vol. 15 (2). Р. 165–170.; Low R.N., Sigeti J.S. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging // AJR Am. J. Roentgenol. 1994. Vol. 163. Р. 1131–1140.; Fujii S., Matsusue E., Kanasaki Y. et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusionweighted MR imaging // Eur. Radiol. 2008. Vol. 18. Р. 18–23. DOI:10.1007/s00330-007-0732-9.; Low R.N., Sebrechts C.P., Barone R.M., Muller W. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings — a feasibility study // AJR Am. J. Roentgenol. 2009. Vol. 193. Р. 461–470. DOI:10.2214/AJR.08.1753.; Low R.N., Barone R.M., Lacey C., Sigeti J.S., Alzate G.D., Sebrechts C.P. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT // Radiology. 1997. Vol. 204. Р. 513–520.; Klumpp B.D, Aschoff P., Schwenzer N., Fenchel M., Koenigsrainer I., Falch C., Bruecher B., Claussen C.D., Koenigsrainer A., Pfannenberg C., Kramer U., Miller S. Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings // Abdom. Imaging. 2012. Oct. Vol. 37 (5). Р. 834–842.; Low R.N. Diffusion-weighted MR imaging for whole body metastatic disease and lymphadenopathy // Magn. Reson. Imaging Clin. N. Am. 2009. Vol. 17. Р. 245–261. DOI:10.1016/j.mric.2009.01.006.
-
4
Authors: Н. А. Рубцова, А. В. Левшакова, А. О. Пешков, В. М. Хомяков, А. Б. Уткина, Д. В. Сидоров, Н. А. Гришин, N. A. Rubtsova, A. V. Levshakova, A. O. Peshkov, V. M. Khomyakov, A. B. Utkina, D. V. Sidorov, N. A. Grishin
Source: Diagnostic radiology and radiotherapy ; Лучевая диагностика и терапия
Subject Terms: peritoneal carcinomatosis, CT, MRI, PCI, перитонеальный карциноматоз, компьютерная томография, магнитно-резонансная томография, индекс перитонеального карциноматоза